2025 annual financial data
LENZ Therapeutics 2025 Net margin
Direct answer
Net margin was -430.25%.
Operating income was -91,138,000 USD and net income was -82,127,000 USD.
Operating cash flow was -69,170,000 USD.
Get free LENZ Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,088,000 USD
- Operating income
- -91,138,000 USD
- Net income
- -82,127,000 USD
- Operating cash flow
- -69,170,000 USD